 WES MOORE, Governor  Ch. 365  
 
– 1 – Chapter 365  
(House Bill 785 ) 
 
AN ACT concerning  
 
Health Insurance – Step Therapy or Fail –First Protocol and Prior Authorization  
– Revisions  
 
FOR the purpose of prohibiting certain  insurers, nonprofit health service plans, and health 
maintenance organizations from imposing a step therapy or fail –first protocol on an 
insured or an enrollee for certain prescription drugs used to treat a certain mental 
disorder or condition;  requiring certain insurers, nonprofit health service plans, or 
health maintenance organizations to establish a certain process for requesting an 
exception to a step therapy or fail –first protocol; prohibiting certain insurers, 
nonprofit health service plans, health maintenance organizations, and pharmacy 
benefits managers from requiring more than a certain number of prior 
authorizations for a prescription for different dosages of the same prescription drug; 
requiring a private review agent to make a determination on a step therapy 
exception request or prior authorization request submitted electronically within a 
certain period of time;  and generally relating to step therapy or fail –first protocols 
and prior authorizations  and health insurance.  
 
BY repealing and reenacting, with amendments,  
 Article – Insurance  
Section 15 –142 and 15 –10B–06(a)  
 Annotated Code of Maryland  
 (2017 Replacement Volume and 2022 Supplement)  
 
BY repealing and reenacting, without amendments,  
 Article – Insurance  
 Section 15 –854(a)  
 Annotated Code of Maryland  
 (2017 Replacement Volume and 2022 Supplement)  
 
BY adding to  
 Article – Insurance  
 Section 15 –854(g)  
 Annotated Code of Maryland  
 (2017 Replacement Volume and 2022 Supplement)  
 
 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY O F MARYLAND, 
That the Laws of Maryland read as follows:  
 
Article – Insurance  
 
15–142. 
Ch. 365  2023 LAWS OF MARYLA ND  
 
– 2 –  
 (a) (1) In this section the following words have the meanings indicated.  
 
  (2) “Step therapy drug” means a prescription drug or sequence of 
prescription drugs required to be used under a step therapy or fail –first protocol.  
 
  (3) “STEP THERAPY EXCEPTIO N REQUEST ” MEANS A REQUEST TO 
OVERRIDE A STEP THER APY OR FAIL –FIRST PROTOCOL . 
 
  [(3)] (4) (I) “Step therapy or fail –first protocol” means a protocol 
established by an insurer, a nonprofit health service plan, or a health maintenance 
organization that requires a prescription drug or sequence of prescription drugs to be used 
by an insured or an enrollee before a prescription drug ordered by a prescriber for the 
insured or  the enrollee is covered.  
 
   (II) “STEP THERAPY OR FAIL –FIRST PROTOCOL ” INCLUDES A 
PROTOCOL THAT MEETS THE DEFINITION UNDER  SUBPARAGRAPH (I) OF THIS 
PARAGRAPH REGARDLESS  OF THE NAME , LABEL , OR TERMINOLOGY USED BY THE 
INSURER , NONPROFIT HEALTH SER VICE PLAN , OR HEALTH MAINTENANC E 
ORGANIZATION TO IDEN TIFY THE PROTOCOL . 
 
  [(4)] (5) “Supporting medical information” means:  
 
   (i) a paid claim from an entity subject to this section for an insured 
or an enrollee;  
 
   (ii) a pharmacy record that documents that a prescription has been 
filled and delivered to an insured or an enrollee, or a representative of an insured or an 
enrollee; or  
 
   (iii) other information mutually agreed on by an entity subject to this 
section and the prescriber of an insured or an enrolle e. 
 
 (b) (1) This section applies to:  
 
   (i) insurers and nonprofit health service plans that provide hospital, 
medical, or surgical benefits to individuals or groups on an expense –incurred basis under 
health insurance policies or contracts that are issue d or delivered in the State; and  
 
   (ii) health maintenance organizations that provide hospital, 
medical, or surgical benefits to individuals or groups under contracts that are issued or 
delivered in the State.  
 
 WES MOORE, Governor  Ch. 365  
 
– 3 –   (2) An insurer, a nonprofit health servic e plan, or a health maintenance 
organization that provides coverage for prescription drugs through a pharmacy benefits 
manager is subject to the requirements of this section.  
 
 (c) An entity subject to this section may not impose a step therapy or fail –first 
protocol on an insured or an enrollee if:  
 
  (1) the step therapy drug has not been approved by the U.S. Food and Drug 
Administration for the medical condition being treated; or  
 
  (2) a prescriber provides supporting medical information to the entity that 
a prescription drug covered by the entity:  
 
   (i) was ordered by a prescriber for the insured or enrollee within the 
past 180 days; and  
 
   (ii) based on the professional judgment of the prescriber, was 
effective in treating the insured’s or enrollee ’s disease or medical condition.  
 
 (d) Subsection (c) of this section may not be construed to require coverage for a 
prescription drug that is not:  
 
  (1) covered by the policy or contract of an entity subject to this section; or  
 
  (2) otherwise required by law to be covered.  
 
 (e) An entity subject to this section may not impose a step therapy or fail –first 
protocol on an insured or an enrollee for a prescription drug approved by the U.S. Food and 
Drug Administration if:  
 
  (1) (I) the prescription drug i s used to treat the insured’s or enrollee’s 
stage four advanced metastatic cancer; and  
 
  [(2)] (II) use of the prescription drug is:  
 
   [(i)] 1. consistent with the U.S. Food and Drug  
Administration –approved indication or the National Comprehensive Cancer Network 
Drugs & Biologics Compendium indication for the treatment of stage four advanced 
metastatic cancer; and  
 
   [(ii)] 2. supported by peer –reviewed medical literature ; OR 
 
  (2) THE PRESCRIPTION DRU G IS USED TO TREAT T HE INSURED ’S OR  
ENROLLEE ’S MENTAL DISORDER OR C ONDITION , AS DEFINED IN THE CU RRENT  
DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS PUBLISHED B Y 
THE AMERICAN PSYCHIATRIC ASSOCIATION , THAT RESULTS IN A SE RIOUS  
Ch. 365  2023 LAWS OF MARYLA ND  
 
– 4 – FUNCTIONAL IMPAIRMEN T THAT SUBSTANTIALLY  INTERFERES WITH OR L IMITS O NE 
OR MORE MAJOR LIFE A CTIVITIES . 
 
 (F) (1) AN ENTITY SUBJECT TO THIS SECTION SHALL E STABLISH A 
PROCESS FOR REQUESTI NG AN EXCEPTION TO A  STEP THERAPY OR FAIL –FIRST 
PROTOCOL THAT IS : 
 
   (I) CLEARLY DESCRIBED , INCLUDING THE SPECIF IC 
INFORMATION AND DOCUMENTATION , IF NEEDED , THAT MUST BE SUBMITT ED BY 
THE PRESCRIBER TO BE CON SIDERED A COMPLETE S TEP THERAPY EXCEPTIO N 
REQUEST ; 
 
   (II) EASILY ACCESSIBLE TO  THE PRESCRIBER ; AND 
 
   (III) POSTED ON THE ENTITY ’S WEBSITE . 
 
  (2) A STEP THERAPY EXCEPTI ON REQUE ST SHALL BE GRANTED IF, 
BASED ON THE PROFESS IONAL JUDGMENT OF TH E PRESCRIBER AND ANY 
INFORMATION AND DOCU MENTATION REQUIRED U NDER PARAGRAPH (1)(I) OF THIS 
SUBSECTION : 
 
   (I) THE STEP THERAPY DRU G IS CONTRAINDICATED  OR WILL 
LIKELY CAUSE AN ADVE RSE REACTION , PHYSICAL HARM , OR MENTAL HARM  TO THE 
INSURED OR ENROLLEE ; 
 
   (II) THE STEP THERAPY DRU G IS EXPECTED TO BE INEFFECTIVE 
BASED ON THE KNOWN C LINICAL CHARACTERIST ICS OF THE INSURED O R ENROLLEE 
AND THE KNOWN CHARAC TERISTICS OF THE PRE SCRIPTION DRUG REGIM EN; 
 
   (III) THE INSURED OR ENROL LEE IS STABLE ON A P RESCRIPTION 
DRUG PRESCRIBED FOR THE MEDICAL CONDITIO N UNDER CONSIDERATIO N WHILE 
COVERED UNDER THE PO LICY OR CONTRACT OF THE ENTITY OR UNDER A PREVIOUS 
SOURCE OF COVERAGE ; OR 
 
   (IV) WHILE COVERED UNDER THE  POLICY OR CONTRACT O F THE 
ENTITY OR A PREVIOUS  SOURCE OF COVERAGE , THE INSURED OR ENROL LEE HAS 
TRIED A PRESCRIPTION  DRUG THAT : 
 
    1. IS IN THE SAME PHARM ACOLOGIC CLASS OR HA S THE 
SAME MECHANISM OF AC TION AS THE STEP THE RAPY DRUG ; AND 
 
 WES MOORE, Governor  Ch. 365  
 
– 5 –     2. WAS DISCONTINUED BY THE PRESCRIBER DUE T O 
LACK OF EFFICACY OR EFFECTIVENESS , DIMINISHED EFFECT , OR AN ADVERSE 
EVENT .  
 
  (3) AN INSURED OR ENROLLE E MAY APPEAL THE DEC ISION TO DENY  
A STEP THERAPY EXCEP TION REQUEST UNDER T HIS SECTION .  
 
  (4) (I) A STEP THER APY EXCEPTION REQUES T OR APPEAL SHALL  
BE GRANTED : 
 
    1. IN REAL TIME IF NO A DDITIONAL INFORMATIO N IS  
NEEDED BY THE ENTITY  TO PROCESS THE REQUE ST AND THE REQUEST M EETS THE  
ENTITY’S CRITERIA FOR APPRO VAL; OR 
 
    2. IF ADDITIONAL INFORM ATION IS NEEDED BY T HE 
ENTITY TO PROCESS TH E REQUEST AND THE RE QUEST IS NOT URGENT , WITHIN 1 
BUSINESS DAY AFTER T HE ENTITY RECEIVES A LL RELEVANT INFORMAT ION NEEDED  
TO PROCESS THE REQUE ST.  
 
   (II) IF AN ENTITY SUBJECT TO THIS SECTION DOES  NOT GRANT  
OR DENY A STEP THERA PY EXCEPTION REQUEST OR  AN APPEAL WITHIN THE  TIME  
PERIOD REQUIRED UNDE R SUBPARAGRAPH (I) OF THIS PARAGRAPH , THE REQUEST  
OR APPEAL SHALL BE T REATED AS GRANTED . 
 
  (3) ON GRANTING A STEP TH ERAPY EXCEPTION REQU EST, AN ENTITY 
SUBJECT TO THIS SECT ION SHALL AUTHORIZE COVERAGE F OR THE PRESCRIPTION 
DRUG ORDERED BY THE PRESCRIBER FOR AN IN SURED OR ENROLLEE . 
 
  (4) AN ENROLLEE OR INSURE D MAY APPEAL A STEP THERAPY 
EXCEPTION REQUEST DE NIAL IN ACCORDANCE W ITH SUBTITLE 10A  OR SUBTITLE 
10B  OF THIS TITLE .  
 
  (5) THIS SUBSECTION MAY NOT B E CONSTRUED TO PREVENT : 
 
   (I) PREVENT : 
 
    1. AN ENTITY SUBJECT TO  THIS SECTION FROM 
REQUIRING AN INSURED  OR ENROLLEE TO TRY A N AB–RATED GENERIC 
EQUIVALENT OR INTERC HANGEABLE BIOLOGICAL  PRODUCT BEFORE PROVI DING 
COVERAGE FOR THE EQUIVALENT BRANDED P RESCRIPTION DRUG ; OR 
 
   (II) 2. A HEALTH CARE PROVID ER FROM PRESCRIBING A 
PRESCRIPTION DRUG TH AT IS DETERMINED TO BE MEDICALLY APPROPR IATE ; OR 
 
Ch. 365  2023 LAWS OF MARYLA ND  
 
– 6 –    (II) REQUIRE AN ENTITY SU BJECT TO THIS SECTIO N TO 
PROVIDE COVERAGE FOR  A PRESCRIPTION DRUG THAT IS NOT COV ERED BY A 
POLICY OR CONTRACT O F THE ENTITY .  
 
  (6) AN ENTITY SUBJECT TO THIS SECTION MAY USE  AN EXISTING STEP 
THERAPY EXCEPTION PR OCESS THAT SATISFIES  THE REQUIREMENTS UND ER THIS 
SUBSECTION .  
 
15–854. 
 
 (a) (1) This section applies to:  
 
   (i) insurers and nonprofit health service plans that provide coverage 
for prescription drugs through a pharmacy benefit under individual, group, or blanket 
health insurance policies or contracts that are issued or delivered in the State; and  
 
   (ii) health maintenance organizations that provide coverage for 
prescription drugs through a pharmacy benefit under individual or group contracts that 
are issued or delivered in the State.  
 
  (2) An insurer, a nonprofit health service plan, or a health maintenance 
organization that provides coverage for prescription drugs through a pharmacy benefits 
manager or that contracts with a private review agent under Subtitle 10B of this article is 
subject to the requirements of this section.  
 
  (3) This section does not apply to a managed care organization as defined 
in § 15 –101 of the Health – General Article.  
 
 (G) (1) EXCEPT AS PROVIDED IN  PARAGRAPH (2) OF THIS SUBSECTION , 
AN ENTITY SUBJECT TO  THIS SECTION MAY NOT  REQUIRE MORE THAN ON E PRIOR 
AUTHORIZATION IF T WO OR MORE TABLETS O F DIFFERENT DOSAGE S TRENGTHS OF 
THE SAME PRESCRIPTIO N DRUG ARE : 
 
   (I) PRESCRIBED AT THE SA ME TIME AS PART OF A N INSURED ’S 
TREATMENT PLAN ; AND  
 
   (II) MANUFACTURED BY THE SAME MANUFACTURER . 
 
  (2) THIS SUBSECTION DOES NOT PROHIBIT AN ENTITY FROM 
REQUIRING MORE THAN ONE PRIOR AUTHORIZAT ION IF THE PRESCRIPT ION IS FOR 
TWO OR MORE TABLETS OF DIFFERENT DOSAGE STRENGTHS OF AN OPIO ID THAT IS 
NOT AN OPIOID PARTIA L AGONIST . 
 
15–10B–06. 
 
 WES MOORE, Governor  Ch. 365  
 
– 7 –  (a) (1) [A] EXCEPT AS PROVIDED IN  PARAGRAPH (4) OF THIS 
SUBSECTION , A private review agent shall:  
 
   (i) make all initial determinations on whether to authorize or certify 
a nonemergency course of treatment for a patient within 2 working days after receipt of the 
information necessary to make the determination;  
 
   (ii) make all determinations on whether to authorize or certify an 
extended stay in a health care facility or additional health care services within 1 working 
day after receipt of the information necessary to make the determination; and  
 
   (iii) prom ptly notify the health care provider of the determination.  
 
  (2) If within 3 calendar days after receipt of the initial request for health 
care services the private review agent does not have sufficient information to make a 
determination, the private rev iew agent shall inform the health care provider that 
additional information must be provided.  
 
  (3) If a private review agent requires prior authorization for an emergency 
inpatient admission, or an admission for residential crisis services as defined in § 15–840 
of this title, for the treatment of a mental, emotional, or substance abuse disorder, the 
private review agent shall:  
 
   (i) make all determinations on whether to authorize or certify an 
inpatient admission, or an admission for residential crisis  services as defined in § 15 –840 
of this title, within 2 hours after receipt of the information necessary to make the 
determination; and  
 
   (ii) promptly notify the health care provider of the determination.  
 
  (4) FOR A STEP THERAPY EX CEPTION REQUEST SUBM ITTED 
ELECTRONICALLY IN AC CORDANCE WITH A PROC ESS ESTABLISHED UNDE R §  
15–142( F) OF THIS TITLE OR A P RIOR AUTHORIZATION R EQUEST SUBMITTED 
ELECTRONICALLY FOR P HARMACEUTICAL SERVIC ES, A PRIVATE REVIEW AGE NT 
SHALL MAKE  A DETERMINATION : 
 
   (I) IN REAL TIME IF : 
 
    1. NO ADDITIONAL INFORM ATION IS NEEDED BY T HE 
PRIVATE REVIEW AGENT  TO PROCESS THE REQUE ST; AND  
 
    2. THE REQUEST MEETS TH E PRIVATE REVIEW AGE NT’S 
CRITERIA FOR APPROVA L; OR 
 
Ch. 365  2023 LAWS OF MARYLA ND  
 
– 8 –    (II) IF A REQUEST IS NOT APPRO VED UNDER ITEM (I) OF THIS 
PARAGRAPH , WITHIN 1 BUSINESS DAY AFTER T HE PRIVATE REVIEW AG ENT 
RECEIVES ALL OF THE INFORMATION NECESSAR Y TO MAKE THE DETERM INATION .  
 
 SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall apply to all 
policies, contracts, a nd health benefit plans issued, delivered, or renewed in the State on or 
after January 1, 2024.  
 
 SECTION 3. AND BE IT FURTHER ENACTED, That this Act shall take effect 
January 1, 2024.  
 
Approved by the Governor, May 3, 2023.  